Senator Investment Group LP Jazz Pharmaceuticals PLC Transaction History

Senator Investment Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $49.7 Million - $58.3 Million	-408,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $71.5 Million - $103 Million	-617,000 Reduced 60.2%	408,000 $50.6 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $805,050 - $902,850	-5,000 Reduced 0.49%	1,025,000 $172 Million
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $68.5 Million - $85.8 Million	-468,295 Reduced 31.26%	1,030,000 $177 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $13.6 Million - $15.7 Million	100,000 Added 7.15%	1,498,295 $226 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $12.9 Million - $14.8 Million	98,295 Added 7.56%	1,398,295 $188 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $185 Million - $202 Million	1,300,000	1,300,000 $190 Million

542

59M

125K

58.4K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.